Neuroendocrine tumor (NET) of the major duodenal papilla is a rare occurrence. However, that of the minor duodenal papilla is even rarer. To date, only a few cases have been reported. Herein, we present a rare case of NETs detected at the major and minor duodenal papilla synchronously, which were successfully treated with endoscopic papillectomy without procedure-related complication. To the best of our knowledge, this is the first report of this kind in the world. Photomicrograph of the biopsy specimen stained immunohistochemically for synaptophysin showed a positive reaction of tumor cells. All resection margins were negative. Further experience with more cases will be needed to establish the exact indication of endoscopic papillectomy for duodenal papillary NETs. (Korean J Gastroenterol 2018;72:217-221) 
INTRODUCTION
Duodenal papillary neuroendocrine tumor (NET) is a rare occurrence, accounting for less than 1% of all gastrointestinal NETs. Therefore, the natural history of this disease entity has not been well established. 1 It has been postulated that the prognosis is generally good, although a small percentage of duodenal papillary NETs can show more aggressive behaviors, such as distant metastasis. Thus, the standard treatment for this lesion has been complete surgical resection. 2 However, pancreaticoduodenectomy, although it allows complete resection, has been shown to be associated with relatively high morbidity and moderate mortality. 1 Local excision shows satisfactory results in tumors <2 cm. 1 Recently, endoscopic papillectomy has been used as a reliable treatment option for duodenal papillary tumors. 3, 4 Endoscopic papillectomy is increasingly being performed on patients with NET of the minor papilla and of the major duodenal papilla as a minimally invasive alternative to radical surgery. 5 Nevertheless, a review of related articles revealed, to the best of our knowledge, that a diagnosis of NET in the major and minor duodenal papilla, simultaneously, which were sub- sequently treated with endoscopic resection, has never been reported to date. We report one such case, with a brief literature review.
CASE REPORT
A 42-year-old woman with pain and soreness at the epigastric area underwent esophagogastroduodenoscopy (EGD)
at a local facility. The biopsy specimen was highly suspicious for adenocarcinoma of the minor papilla. She was then referred to our facility for closer examination. The patient had no history of hypertension or diabetes mellitus, and no drink- duct dilatation were not observed on the magnetic resonance cholangiopancreatography (Fig. 1) .
According to the pathologic report, endoscopic snare papillectomy was performed for accurate diagnosis and treatment, which was based on patient's hesitancy to undergo surgery (Fig. 2) . At the time of the procedure, red infiltrative changes were observed in the bottom of the major papilla, and a further biopsy was performed concurrently. The resected specimen measured 1.7×1.3 cm. The patient was discharged after the procedure, without complications, such as bleeding or perforation. The pathologic examination of the minor papilla showed that the lesion was localized to the deep mucosal layer and submucosa, and there was no involvement of the resection margin. According to microscopy, the tumor cells were arranged in a fibrous or rosette form, with a round nuclei and granular chromatin; mitosis was rarely observed (1 per 10 high-powered fields). On immunohistochemistry, both synaptophysin and Ki-67 were positive. The Ki-67 index was <2%, which was consistent with NET ( Fig. 3) . The tumor diameter was 1.2×1.1 cm, suggesting a well-differentiated, low-grade NET with a World Health Organization (WHO) grade of I.
The patient was later re-admitted because NET was also observed on histologic examination of the major papilla.
Positron emission tomography was performed, but showed no suspicious metastases. Endoscopic papillectomy was also performed of the major papilla (Fig. 4) , and a tumor with a size of 1.6×1.2 cm was observed. The tumor was limited to the sphincter of Oddi and perisphincteric submucosa. There was no tumor involvement at the resection margins.
Microscopic and immunohistochemistry findings were the same as those of the minor papilla (Fig. 5) . Since the diagnosis, the patient has undergone follow-up for 16 months without recurrence on repeated EGD and CT.
DISCUSSION
The Surveillance, Epidemiology, and End Results Program from the National Cancer Institute reported only 1.35% of NETs among all malignant neoplasms of the ampulla of Vater (AOV). 6 However, the incidence rate has apparently increased in recent years, likely due to the generalization of EGD for screening and the development of diagnostic technologies. and G1/G2 NETs showed favorable prognosis. 11 Currently, endoscopic resection and surgical ampullectomy have been considered to be safe for small NETs of the AOV (<2 cm) or in patients with severe comorbidities. 12, 13 NETs located in the minor duodenal papilla are extremely rare, and as of 2016, only 15 cases have been described in the English literature. 14 However, in a single autopsy and surgical specimen study, NETs of the minor duodenal papilla were twice as common as those of the major duodenal papilla. 15 The reason NETs of the major duodenal papilla are discovered more frequently than those of the minor duodenal papilla in the clinical practice may be that the former is more likely to cause symptoms, such as jaundice or abdominal pain due to papillary obstruction. Conversely, NETs of the minor duodenal papilla seldom cause symptoms, as there is no biliary or pancreatic obstruction. 16 Moreover, NETs arising from the minor papilla are not easy to diagnose preoperatively due to its relatively small size and submucosal location. 17 The frequency of lymph node metastasis from duodenal papillary NETs is 60-66%, although it has been shown that this variant is not related to the overall survival, as the 5-year survival rate is about 90%. However, the prognosis is rather poor, especially when there are hepatic metastases; the prognosis for minor papilla NETs remains unknown. 8 The Japanese-language literature reports 19 cases who underwent pancreaticoduodenectomy for NET of the minor duodenal papilla. Most patients with tumors measuring 1.0-2.0 cm had lymph node metastasis; it appears that NETs arising from the minor duodenal papilla have a high propensity for lymph node metastasis, like the major duodenal papilla. 18 The treatment of choice for NETs of the duodenal papilla is complete resection, and the standard treatment modality is pancreaticoduodenectomy. 10 Although a pancreaticoduodenectomy enables complete resection of the tumor, this procedure seems to be associated with disadvantages due to relatively high morbidity, as well as moderate levels of mortality. 1 Local excision shows satisfactory results in tumors smaller than 2 cm. 1 Compared to local resection, endoscopic papillectomy is much less invasive because it does not require laparotomy or duodenectomy.
Complications related to endoscopic snare papillectomy are self-limiting. 3 In a recently published article, complications occurred in 18.5% (n=10/54) of cases: bleeding (n=3); pancreatitis (n=7), and perforation (n=1; the only case requiring rescue surgical intervention). There was no intervention-related death (mortality, 0%). 4 Endoscopic snare papillectomy may be considered as the first step in the management of small NETs (<1 cm) of the AOV when radical resection appears to be difficult or poorly tolerated. 19 In this case, pancreaticoduodenectomy was initially recommended; however, the patient refused to undergo surgery. Endoscopic papillectomy was successfully performed sequentially.
We report the first case of endoscopic papillectomy of simultaneous neuroendocrine tumors in the major and minor duodenal papilla. Long-term follow-up is needed to better determine the ultimate outcome. Endoscopic papillectomy is considered a treatment option when radical surgery seems to be difficult or poorly tolerated.
